These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38599533)

  • 1. Clinician Ordering and Management Patterns of Urine Toxicology Results at a Cancer Center.
    Yusufov M; Melanson SEF; Kang P; Kematick B; Schiff GD; Chua IS
    J Pain Symptom Manage; 2024 Jul; 68(1):e36-e45. PubMed ID: 38599533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain.
    Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK
    Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic.
    Arthur JA; Edwards T; Lu Z; Reddy S; Hui D; Wu J; Liu D; Williams JL; Bruera E
    Cancer; 2016 Dec; 122(23):3732-3739. PubMed ID: 27509305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
    LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
    JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory-Generated Urine Toxicology Interpretations: A Mixed Methods Study.
    Chua IS; Ransohoff JR; Ehrlich O; Katznelson E; Virk ZM; Demetriou CA; Petrides AK; Orav EJ; Schiff GD; Melanson SEF
    Pain Physician; 2021 Mar; 24(2):E191-E201. PubMed ID: 33740356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.
    Wyse JJ; Morasco BJ; Dobscha SK; Demidenko MI; Meath THA; Lovejoy TI
    J Opioid Manag; 2018; 14(4):295-303. PubMed ID: 30234926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random urine drug testing among patients receiving opioid therapy for cancer pain.
    Arthur JA; Tang M; Lu Z; Hui D; Nguyen K; Rodriguez EM; Edwards T; Yennurajalingam S; Dalal S; Dev R; Reddy A; Tanco K; Haider A; Liu DD; Bruera E
    Cancer; 2021 Mar; 127(6):968-975. PubMed ID: 33231885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
    Turner JA; Saunders K; Shortreed SM; Rapp SE; Thielke S; LeResche L; Riddell KM; Von Korff M
    J Gen Intern Med; 2014 Feb; 29(2):305-11. PubMed ID: 24142119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results.
    Chua I; Petrides AK; Schiff GD; Ransohoff JR; Kantartjis M; Streid J; Demetriou CA; Melanson SEF
    J Gen Intern Med; 2020 Jan; 35(1):283-290. PubMed ID: 31713040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the Pain Medication Questionnaire to predict aberrant urine drug tests: Results from a longitudinal cohort study.
    Morasco BJ; Iacocca MO; Lovejoy TI; Dobscha SK; Deyo RA; Cavese JA; Hyde S; Yarborough BJH
    Psychol Serv; 2021 Aug; 18(3):319-327. PubMed ID: 32673038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer Pain.
    Koyyalagunta D; Bruera E; Engle MP; Driver L; Dong W; Demaree C; Novy DM
    Pain Med; 2018 Jul; 19(7):1469-1477. PubMed ID: 29016951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.
    Turner JA; Saunders K; Shortreed SM; LeResche L; Riddell K; Rapp SE; Von Korff M
    J Gen Intern Med; 2014 Dec; 29(12):1663-71. PubMed ID: 25217208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine Drug Testing in Cancer Pain Management.
    Arthur JA
    Oncologist; 2020 Feb; 25(2):99-104. PubMed ID: 32043770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic urine drug testing for detecting and managing opioid misuse among chronic noncancer pain patients in primary care-The HARMS Program: A retrospective chart review of 77 patients.
    Shahi N; Patchett-Marble R
    J Opioid Manag; 2020; 16(4):277-282. PubMed ID: 32885835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans.
    Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK
    Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Nevada primary care clinicians' use of urine drug testing to mitigate opioid harm.
    Hartzell SYT; Keller MS; Albertson EM; Liu Y; Larson M; Friedman S
    J Subst Use Addict Treat; 2023 Feb; 145():208940. PubMed ID: 36880912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Screening Practices in the Cancer Pain Patient.
    Liebling D; Mehta N; Gulati A
    J Palliat Med; 2019 Jan; 22(1):10-17. PubMed ID: 30153080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Prevalence of and Risk Factors for Abnormal Urine Drug Tests in Cancer Pain Patients.
    Leap KE; Chen GH; Lee J; Tan KS; Malhotra V
    J Pain Symptom Manage; 2021 Aug; 62(2):355-363. PubMed ID: 33276043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.